<DOC>
	<DOCNO>NCT01109758</DOCNO>
	<brief_summary>The purpose study assess fenofibrate modify gene expression circulate monocyte healthy volunteer 6 week .</brief_summary>
	<brief_title>Effects Fenofibrate Gene Expression Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Male female , To age 4065 year , To post menopausal female receive hormone replacement therapy , To normal homocysteine , folate vitamin B12 level baseline ( result available initiation treatment ) , To good health determine medical history , physical examination , ECG , vital sign , serum/urine biochemistry hematology . Subjects clinically relevant evidence cardiovascular , gastrointestinal/hepatic , renal , neurologic/psychiatric emotional , respiratory , urogenital , hematologic/immunologic , HEENT ( head , ears , eye , nose , throat ) , dermatologic/connective tissue , musculoskeletal , metabolic/nutritional , drug hypersensitivity , ( drug ) allergy , endocrine , major surgery relevant diseases revealed medical history , physical examination , laboratory assessment may interfere absorption , distribution , metabolism elimination drug constitute risk factor take study medication , Subjects treat fenofibrate previous study , Subjects take single dose investigational drug within 30 day multiple dos investigational drug within 60 day prior dose</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Fenofibrate</keyword>
	<keyword>Gene Expression</keyword>
	<keyword>DNA methylation</keyword>
</DOC>